# Build a therapeutic-area intelligence briefing Canonical URL: https://biopharmsignal.com/use-cases/biotech-competitive-intelligence/build-a-therapeutic-area-intelligence-briefing Role: [Biotech Competitive Intelligence Teams](https://biopharmsignal.com/use-cases/biotech-competitive-intelligence.md) Category: Internal intelligence delivery Last updated: 2026-07-26 Summarize evidence, landscape changes, and upcoming events. ## The Situation Cross-functional leaders need a recurring view of important scientific, clinical, regulatory, commercial, and transaction changes in one therapeutic area. ### Best Fit Competitive intelligence, business development, corporate strategy, clinical, regulatory, and commercial teams inside biotech and pharmaceutical companies. ## The Challenge Summarize evidence, landscape changes, and upcoming events. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. ## How To Think About The Task Cross-functional leaders need a recurring view of important scientific, clinical, regulatory, commercial, and transaction changes in one therapeutic area. For competitive intelligence, the useful response is not simply to collect more links. The task is to decide what the new information changes, which source supports it, who needs to respond, and when the question should be reviewed again. Summarize evidence, landscape changes, and upcoming events. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. A repeatable process keeps the work proportional to the decision and creates a record that another investor, analyst, editor, or team member can understand later. ### Start with the decision this work must support “Build a therapeutic-area intelligence briefing” becomes manageable when the user names the decision before opening more sources. The decision might be whether to escalate an event, update a thesis, change a calendar, commission deeper research, publish a story, or continue monitoring. A defined decision also makes it easier to exclude information that is interesting but not currently useful. ### Build a source-linked change record The core monitoring set for this workflow includes material landscape changes, new evidence, regulatory developments, transactions and strategy, upcoming events. Each material update should retain its source and previous known state. That makes timing changes, accumulating evidence, and repeated execution patterns visible instead of leaving the user with an isolated snapshot. ### Turn monitoring into an owned output A periodic intelligence briefing organized by what changed, why it matters, affected internal assumptions, and required follow-up. The output should state what changed, what remains uncertain, who owns any follow-up, and which future event will resolve the question. Stakeholders receive a decision-oriented update rather than a broad collection of industry headlines. ## Illustrative Example ### Illustrative workflow: build a therapeutic-area intelligence briefing Begin with the specific company, program, portfolio exposure, audience, or competitive set in scope. Review the highest-confidence source first, compare the disclosure with the previous record, and then use secondary context only where it helps explain the change. Complete the workflow by producing the defined deliverable rather than ending with a collection of tabs. Assign any unresolved question to an owner and set the next review around the most relevant clinical, regulatory, financial, strategic, or editorial event. ### Questions To Answer Before Making A Decision - What has changed in material landscape changes, and why does it matter? - What has changed in new evidence, and why does it matter? - What has changed in regulatory developments, and why does it matter? - What has changed in transactions and strategy, and why does it matter? - What has changed in upcoming events, and why does it matter? ## A Repeatable Workflow 1. Define the specific decision or research question behind “build a therapeutic-area intelligence briefing.” 2. Set the monitored scope around material landscape changes and new evidence. 3. Collect source-linked updates for regulatory developments and record what changed from the prior state. 4. Review transactions and strategy together with upcoming events before drawing a conclusion. 5. Produce the required output, assign follow-up ownership, and set the next review point. ## Signals To Keep Visible - Material landscape changes - New evidence - Regulatory developments - Transactions and strategy - Upcoming events ## Common Mistakes - Starting the monitoring process without a defined decision question - Recording the latest state without preserving its source or previous state - Ending with collected information but no owner, conclusion, or next review ## Deliverable A periodic intelligence briefing organized by what changed, why it matters, affected internal assumptions, and required follow-up. ## Practical Outcome Stakeholders receive a decision-oriented update rather than a broad collection of industry headlines. ## Where BioPharmSignal Fits Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep relevant tickers and keywords visible. The workflow still requires independent research and judgment. ## Frequently Asked Questions ### Who is this workflow for? It is designed for biotech competitive intelligence teams and adjacent biotech research users who need a repeatable, source-linked way to complete this task. ### What should this workflow produce? A periodic intelligence briefing organized by what changed, why it matters, affected internal assumptions, and required follow-up. ### What is the practical benefit? Stakeholders receive a decision-oriented update rather than a broad collection of industry headlines. ## Related Workflows - [How Biotech Teams Map a Competitive Target Landscape](https://biopharmsignal.com/use-cases/biotech-competitive-intelligence/map-biotech-target-landscape.md) - [How Biotech Teams Monitor Competitor Clinical Progress](https://biopharmsignal.com/use-cases/biotech-competitive-intelligence/monitor-competitor-clinical-progress.md) - [How Biotech BD Teams Identify Partnership Signals](https://biopharmsignal.com/use-cases/biotech-competitive-intelligence/identify-biotech-partnership-signals.md) Format note: This is an illustrative workflow guide, not a named customer testimonial or a claim of investment performance.